CytoMed Therapeutics Ltd
For the period ended Dec 31, 2024. Filed Apr 28, 2025.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2024 · Filed Apr 28, 2025
Contents
MATERIAL CONTRACTS
| C. | Material Contracts |
|---|
Attached as exhibits to this annual report or incorporated by reference herein are the contracts we consider to be both material and outside the ordinary course of business immediately preceding the date of this annual report. We refer you to “Item 4. Information on the Company”,“Employment Agreements” under “Item 6. Directors, Senior Management and Employees”, and under “Item 7. Major Shareholders and Related Party Transactions” of this annual report for a discussion of these contracts. Other than as discussed in this annual report, we have no material contracts, other than contracts entered into in the ordinary course of business, to which we are a party.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.